Source: MarketScreener

Shanghai Fudan-zhangjiang: Shanghai Fudan Zhangjiang Bio Pharmaceutical : INSIDE INFORMATION-PROPOSED GRANT OF GENERAL MANDATE TO THE BOARD OF DIRECTORS TO REPURCHASE H SHARES

(marketscreener.com) Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of...https://www.marketscreener.com/quote/stock/SHANGHAI-FUDAN-ZHANGJIANG-6171207/news/Shanghai-Fudan-Zhangjiang-Bio-Pharmaceutical-nbsp-INSIDE-INFORMATION-PROPOSED-GRANT-OF-GENERAL-MAN-32785265/?utm_medium=RSS&utm_content=20210325

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
500-1.0K
CEO Avatar

General Manager

Haibo Wang

CEO Approval Rating

70/100

Read more